Clinical Trials Directory

Trials / Conditions / Catecholaminergic Polymorphic Ventricular Tachycardia

Catecholaminergic Polymorphic Ventricular Tachycardia

11 registered clinical trials studyying Catecholaminergic Polymorphic Ventricular Tachycardia — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
NCT07148089
Solid Biosciences Inc.Phase 1
RecruitingSafety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventri
NCT07263139
Agiana PharmaceuticalsPhase 2
RecruitingA Phase 2 Study of CRD-4730 in CPVT
NCT06658899
Cardurion Pharmaceuticals, Inc.Phase 2
RecruitingNational Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in B
NCT06546137
Hospital do Coracao—
CompletedBaby Detect : Genomic Newborn Screening
NCT05687474
Centre Hospitalier Universitaire de Liege—
RecruitingClinical Cohort Study - TRUST
NCT05521451
Universitätsklinikum Hamburg-Eppendorf—
CompletedHealthy-related Quality of Life and Physical Activity of Children With Cardiac Malformations
NCT04712136
University Hospital, MontpellierN/A
CompletedPhysical Activity in Children With Inherited Cardiac Diseases
NCT04650009
University Hospital, Montpellier—
CompletedAtropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
NCT02927223
Vanderbilt UniversityN/A
CompletedLong Term Monitoring for Risk of Sudden Death
NCT04124237
University of British Columbia—
CompletedFlecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
NCT01117454
Vanderbilt University Medical CenterN/A